Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Structure and stability of internodal myelin in mouse models of hereditary neuropathy.

Avila RL, Inouye H, Baek RC, Yin X, Trapp BD, Feltri ML, Wrabetz L, Kirschner DA.

J Neuropathol Exp Neurol. 2005 Nov;64(11):976-90.

PMID:
16254492
2.

Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy.

Gilardini A, Avila RL, Oggioni N, Rodriguez-Menendez V, Bossi M, Canta A, Cavaletti G, Kirschner DA.

Neurotoxicology. 2012 Jan;33(1):1-7. doi: 10.1016/j.neuro.2011.10.010. Epub 2011 Nov 4.

PMID:
22079976
3.

P0 (protein zero) mutation S34C underlies instability of internodal myelin in S63C mice.

Avila RL, D'Antonio M, Bachi A, Inouye H, Feltri ML, Wrabetz L, Kirschner DA.

J Biol Chem. 2010 Dec 31;285(53):42001-12. doi: 10.1074/jbc.M110.166967. Epub 2010 Oct 11.

4.

Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.

Patzig J, Kusch K, Fledrich R, Eichel MA, Lüders KA, Möbius W, Sereda MW, Nave KA, Martini R, Werner HB.

Glia. 2016 Jan;64(1):155-74. doi: 10.1002/glia.22922. Epub 2015 Sep 22.

PMID:
26393339
5.

Role of immune cells in animal models for inherited peripheral neuropathies.

Wang Ip C, Kroner A, Fischer S, Berghoff M, Kobsar I, Mäurer M, Martini R.

Neuromolecular Med. 2006;8(1-2):175-90. Review.

PMID:
16775375
6.

Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies.

Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M.

Nat Genet. 1995 Nov;11(3):281-6.

PMID:
7581451
7.

Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice.

Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K, Avila RL, Kirschner DA, Messing A, Feltri ML, Quattrini A.

J Neurosci. 2006 Feb 22;26(8):2358-68.

8.

Neuregulin 1-erbB signaling is necessary for normal myelination and sensory function.

Chen S, Velardez MO, Warot X, Yu ZX, Miller SJ, Cros D, Corfas G.

J Neurosci. 2006 Mar 22;26(12):3079-86.

9.

Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.

Rünker AE, Kobsar I, Fink T, Loers G, Tilling T, Putthoff P, Wessig C, Martini R, Schachner M.

J Cell Biol. 2004 May 24;165(4):565-73. Epub 2004 May 17.

10.

Effective gene transfer of lacZ and P0 into Schwann cells of P0-deficient mice.

Guénard V, Schweitzer B, Flechsig E, Hemmi S, Martini R, Suter U, Schachner M.

Glia. 1999 Jan 15;25(2):165-78.

PMID:
9890631
11.

Charcot-Marie-Tooth disease and related inherited neuropathies.

Murakami T, Garcia CA, Reiter LT, Lupski JR.

Medicine (Baltimore). 1996 Sep;75(5):233-50. Review.

12.

Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.

Musner N, Sidoli M, Zambroni D, Del Carro U, Ungaro D, D'Antonio M, Feltri ML, Wrabetz L.

ASN Neuro. 2016 Apr 19;8(2). pii: 1759091416642351. doi: 10.1177/1759091416642351. Print 2016 Mar-Apr.

13.
14.

Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.

Anderson TD, Davidovich A, Feldman D, Sprinkle TJ, Arezzo J, Brosnan C, Calderon RO, Fossom LH, DeVries JT, DeVries GH.

Lab Invest. 1994 May;70(5):724-39.

PMID:
7515130
15.

Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects.

Kirschner DA, Szumowski K, Gabreëls-Festen AA, Hoogendijk JE, Bolhuis PA.

J Neurosci Res. 1996 Nov 15;46(4):502-8.

PMID:
8950710
16.

Proteolipid protein cannot replace P0 protein as the major structural protein of peripheral nervous system myelin.

Yin X, Kiryu-Seo S, Kidd GJ, Feltri ML, Wrabetz L, Trapp BD.

Glia. 2015 Jan;63(1):66-77. doi: 10.1002/glia.22733. Epub 2014 Jul 28.

17.

The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.

Barbaria EM, Kohl B, Buhren BA, Hasenpusch-Theil K, Kruse F, Küry P, Martini R, Müller HW.

Neurobiol Dis. 2009 Mar;33(3):448-58. doi: 10.1016/j.nbd.2008.11.014. Epub 2008 Dec 10.

PMID:
19111616
19.

Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.

Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R.

Brain. 2015 Nov;138(Pt 11):3193-205. doi: 10.1093/brain/awv240. Epub 2015 Aug 21.

PMID:
26297559
20.

Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice.

Previtali SC, Quattrini A, Fasolini M, Panzeri MC, Villa A, Filbin MT, Li W, Chiu SY, Messing A, Wrabetz L, Feltri ML.

J Cell Biol. 2000 Nov 27;151(5):1035-46.

Supplemental Content

Support Center